Cancer Vaccines Market Size Is Anticipated To Reach A Valuation Of $12,814 Million, Analysis By Top Key Players Astrazeneca Plc., Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Aduro BioTech Inc. & Many Others.

Global Cancer Vaccines Market is expected to reach at $12,814 million from $4,073 million and register a CAGR of 17.7%, during the forecast period, 2017 - 2023.

Vaccine is a biological preparation administered to produce acquired immunity in patients as well as healthy individuals. Cancer vaccines are a type of biological therapy that prevents and heals various types of cancer, such as, cervical cancer, prostate cancer, lung cancer, breast cancer, and others. These vaccines are designed specifically to recognize and reduce the growth of cancer cells by the immune system. Moreover, cancer vaccines are expected to reduce the prevalence and incidence rate of cancer.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1453

Vaccines include antigenic components, which strengthens an individuals immune system by developing adaptive immunity to prevent morbidity from infections. Cancer vaccine is a type of immunotherapy that boost the bodys natural defenses by stimulating the immune system to recognize and cure cancerous cells.

The global market is driven by rise in prevalence of HPV infections and related cancer, increase in administration of prophylactic cancer vaccines, surge in investments & findings in the development of cancer vaccines, and launch of novel cancer vaccines in the market. However, longer timelines required for manufacturing a single vaccine restrain the development of new vaccines; thereby, hampering the market growth. In addition, high monetary inputs for the development of cancer vaccines decrease their adoption in the market; thereby, hampering the market growth.

The cervical cancer segment accounted for maximum market revenue in 2016, and is anticipated to maintain its dominant position during the forecast period, owing to the increase in number of people suffering from human papilloma virus (HPV) infections, which causes approximately 70% of cervical cancers globally. In addition, high prevalence of cervical, prostate, lungs, and breast cancer among adults propel the market growth. However, prostate cancer is growing at the highest CAGR of 18.6% from 2017 to 2023, owing to the increase in demand for Provenge (prostate cancer vaccine) along with the increase in number of prostate cancer vaccines in the pipeline.

The recombinant cancer vaccines segment dominated the global market in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the large number of approved cancer vaccines developed using recombinant technology such as Cervarix, Gardasil, and Recombivax HB. The therapeutic cancer vaccines segment is anticipated to register the highest growth rate during the forecast period, owing to the increase in transition from prophylactic cancer vaccines to therapeutic cancer vaccines.

Get Customized Report as Required @ https://www.alliedmarketresearch.com/request-for-customization/1453

Asia-Pacific witnessed the highest growth rate for cancer vaccines in 2016, and is expected to continue this trend throughout the forecast period. This is attributed to large population base, rise in incidence of HPV infection related cancers & other cancer cases, healthcare infrastructural development, and huge market potential. Moreover, the introduction of novel preventive, therapeutic, and adult cancer vaccines in the market along with the increasing focus by key players in the emerging markets has fueled the growth of the industry.

The key players operating in the vaccines market have adopted product launch as their key developmental strategy and focus on launching innovative products to cater to the consumer requirements and strengthen their market shares. The major companies profiled in the report include

• Astrazeneca Plc. (Medimmune, LLC.),
• Glaxosmithkline Plc.,
• Merck & Co., Inc.,
• Sanofi Pasteur,
• Aduro BioTech Inc.,
• Sanpower Group,
• Astellas Pharma Inc.,
• CSL Limited,
• Pfizer Inc., and
• Serum Institute of India Pvt. Ltd.

Table Of Content


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising prevalence of human papilloma virus (HPV) infections, causing cancers
3.6.1.2. Increasing administration of prophylactic cancer vaccines
3.6.1.3. Rising investments and government funding in the development of cancer vaccines
3.6.1.4. Launch and approval of new cancer vaccines in the market

3.6.2. Restraints

3.6.2.1. High cost for development of cancer vaccines due to the need of frequent upgradation in manufacturing technology
3.6.2.2. Longer timelines required for manufacturing a single vaccine

3.6.3. Opportunities

3.6.3.1. Increasing transition from prophylactic to therapeutic cancer vaccines
3.6.3.2. High growth prospects in emerging markets

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/cancer-vaccines-market.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.